CINECA IRIS Institutional Research Information System

TALIANI, SABRINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.216
AS - Asia 10.294
EU - Europa 8.866
SA - Sud America 1.294
Continente sconosciuto - Info sul continente non disponibili 662
AF - Africa 466
OC - Oceania 70
Totale 41.868
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.509
IT - Italia 3.595
SG - Singapore 3.025
CN - Cina 2.705
HK - Hong Kong 1.413
VN - Vietnam 1.395
SE - Svezia 1.275
BR - Brasile 1.047
DE - Germania 902
BG - Bulgaria 551
CA - Canada 530
GB - Regno Unito 446
TR - Turchia 432
FR - Francia 412
FI - Finlandia 381
AT - Austria 318
RU - Federazione Russa 312
IN - India 279
JP - Giappone 278
UA - Ucraina 209
KR - Corea 189
CI - Costa d'Avorio 104
BD - Bangladesh 101
NG - Nigeria 86
CH - Svizzera 85
IQ - Iraq 80
MX - Messico 79
NL - Olanda 76
AR - Argentina 73
SN - Senegal 64
AU - Australia 63
PL - Polonia 60
ZA - Sudafrica 60
BE - Belgio 56
PK - Pakistan 55
ES - Italia 52
ID - Indonesia 45
SA - Arabia Saudita 43
UZ - Uzbekistan 40
CO - Colombia 35
VE - Venezuela 35
EC - Ecuador 33
EG - Egitto 31
KE - Kenya 28
JO - Giordania 25
MA - Marocco 22
JM - Giamaica 21
CZ - Repubblica Ceca 20
MY - Malesia 19
IE - Irlanda 18
PY - Paraguay 18
AZ - Azerbaigian 17
CL - Cile 17
DZ - Algeria 17
CR - Costa Rica 16
LT - Lituania 16
PE - Perù 15
AE - Emirati Arabi Uniti 14
PH - Filippine 14
TT - Trinidad e Tobago 14
KZ - Kazakistan 13
OM - Oman 13
TW - Taiwan 13
ET - Etiopia 12
IR - Iran 12
IL - Israele 11
PT - Portogallo 11
BO - Bolivia 10
HU - Ungheria 10
LB - Libano 10
AL - Albania 9
GE - Georgia 8
GR - Grecia 8
PA - Panama 8
BJ - Benin 7
DK - Danimarca 7
UY - Uruguay 7
NZ - Nuova Zelanda 6
PR - Porto Rico 6
PS - Palestinian Territory 6
BF - Burkina Faso 5
BH - Bahrain 5
BN - Brunei Darussalam 5
DO - Repubblica Dominicana 5
EE - Estonia 5
GT - Guatemala 5
NP - Nepal 5
RO - Romania 5
TN - Tunisia 5
BY - Bielorussia 4
LY - Libia 4
NI - Nicaragua 4
QA - Qatar 4
SV - El Salvador 4
TH - Thailandia 4
BA - Bosnia-Erzegovina 3
BB - Barbados 3
CG - Congo 3
GD - Grenada 3
GY - Guiana 3
Totale 41.141
Salva come PNG Salva come JPEG
Città #
Ashburn 1.910
Woodbridge 1.762
Singapore 1.688
Ann Arbor 1.493
Hong Kong 1.369
Houston 1.322
Serra 1.185
San Jose 1.148
Fairfield 1.039
Chandler 1.031
Santa Clara 961
Dallas 875
Milan 661
Sofia 550
Beijing 531
Shanghai 529
Council Bluffs 485
New York 450
Seattle 427
Wilmington 397
Ho Chi Minh City 383
Ottawa 377
Los Angeles 359
Cambridge 329
Boardman 298
Hanoi 284
Izmir 282
Vienna 267
Princeton 264
Jacksonville 254
Hefei 251
Lawrence 220
Lauterbourg 217
Tokyo 203
Frankfurt am Main 192
Nanjing 177
Seoul 177
Medford 175
London 167
Des Moines 154
Dong Ket 147
Helsinki 143
Pisa 143
Rho 129
Istanbul 107
Rome 106
Abidjan 104
Redondo Beach 103
Dearborn 102
Buffalo 98
Munich 88
São Paulo 87
Lagos 83
Chicago 76
Bremen 75
Florence 74
Da Nang 64
Dakar 64
San Diego 62
Columbus 61
Nanchang 60
Turku 60
Brussels 55
Bern 54
Orem 52
The Dalles 51
Redwood City 50
Boulder 48
Ogden 48
Haiphong 46
Kunming 45
Lucca 45
Warsaw 45
Toronto 43
Düsseldorf 42
Pune 42
Jüchen 41
Sydney 41
San Francisco 39
Changsha 38
Fuzhou 38
Shenyang 38
Tashkent 38
Montreal 37
Atlanta 36
Hebei 35
Johannesburg 34
Tianjin 33
Paris 32
Belo Horizonte 31
Livorno 31
Phoenix 31
Baltimore 30
Dhaka 29
Rio de Janeiro 29
Manchester 28
Guangzhou 27
Nuremberg 27
Nürnberg 27
Baghdad 26
Totale 28.341
Salva come PNG Salva come JPEG
Nome #
1,2-Benzisothiazole Derivatives Bearing 4-, 5-, or 6-Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and Cell Proliferation under Hypoxic Conditions 421
Metformin conjugates and therapeutic use thereof 392
TSPO ligand residence time influences human glioblastoma multiforme cell death/life balance 339
18 kDa TSPO targeting drives polarized human microglia towards a protective and restorative neurosteroidome profile 319
Iminothioethers as Hydrogen Sulfide Donors: From the Gasotransmitter Release to the Vascular Effects 301
N, N-Dialkyl-2-phenylindol-3-ylglyoxylamides.A new class of potent and selective ligands at the Peripheral benzodiazepine receptor 295
Benzofuroxane Derivatives as Multi Effective Agents for the Treatment of Cardiovascular Diabetic Complications. Synthesis, Functional Evaluation, and Molecular Modeling Studies 279
Exploiting the Pyrazolo[3,4-d]pyrimidin-4-one ring system as a useful template to obtain potent adenosine deaminase inhibitors, 279
Apoptosis Therapy in Cancer: The First Single-molecule Co-activating p53 and the Translocator Protein in Glioblastoma 278
TSPO PIGA ligands promote neurosteroidogenesis and human astrocyte well-being 272
Bax Activation Blocks Self-Renewal and Induces Apoptosis of Human Glioblastoma Stem Cells 260
Two mixed valence diruthenium(ii,iii) isomeric complexes show different anticancer properties 260
The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities 248
Deepening the Topology of the Translocator Protein Binding Site by Novel N,N-Dialkyl-2-arylindol-3-ylglyoxylamides 247
Translocator Protein 18-kDa: a promising target to treat neuroinflammation-related degenerative diseases 247
[1,2,4]Triazino[4,3-a]benzimidazole Acetic Acid Derivatives: a New Class of Selective Aldose Reductase Inhibitors 240
Allosteric modulators of human A2B adenosine receptor. 239
G-Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitors: Current Trends and Future Perspectives. 236
TSPO-ligands prevent oxidative damage and inflammatory response in C6 glioma cells by neurosteroid synthesis 235
TSPO ligand residence time: a new parameter to predict compound neurosteroidogenic efficacy 235
Sulfonamides incorporating heteropolycyclic scaffolds show potent inhibitory action against carbonic anhydrase isoforms I, II, IX and XII 234
A complex bearing TSPO PIGA ligand coordinated to the [Au(PEt3)]+ pharmacophore is highly cytotoxic against ovarian cancer cells 227
[1,2,4]Triazino[4,3-a]benzimidazole Acetic Acid Derivatives: A New Class of Selective Aldose Reductase Inhibitors 225
A mixed-valence diruthenium(ii,iii) complex endowed with high stability: from experimental evidence to theoretical interpretation 224
TSPO Radioligands for Neuroinflammation: An Overview 220
p53 Functional Inhibitors Behaving Like Pifithrin-β Counteract the Alzheimer Peptide Non-β-amyloid Component Effects in Human SH-SY5Y Cells. 220
Structure-Based Lead Optimization and Biological Evaluation of BAX Direct Activators as Novel Potential Anticancer Agents. 218
Long lasting inhibition of Mdm2-p53 interaction potentiates mesenchymal stem cell differentiation into osteoblasts 218
3-aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-ones: Tricyclic heteroaromatic derivatives as a new class of benzodiazepine receptor ligands 216
Investigation of new 2-aryl substituted Benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors targeting vascular endothelial growth factor receptor 2 216
A cyanine-based NIR fluorescent Vemurafenib analog to probe BRAFV600E in cancer cells 215
An update into the medicinal chemistry of translocator protein (TSPO) ligands 215
Identification of Anxiolytic/Nonsedative Agents among Indol-3-ylglyoxylamides Acting as Functionally Selective Agonists at the γ-Aminobutyric Acid-A (GABAA) α2 Benzodiazepine Receptor 212
Phenylpyrazolo[1,5-a]quinazolin-5(4H)-one: a suitable scaffold for the development of non-camptothecin Topoisomerase I (Top1) inhibitors 212
3-Aryl[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-ones: A New Class of Selective A1 Adenosine Receptor Antagonists 210
3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: A Novel Template for the Design of Highly Selective A(2B) Adenosine Receptor Antagonists. 210
Benzothiopyranoindole- and pyridothiopyranoindole-based antiproliferative agents targeting topoisomerases 209
Discovery of Pyrido[3′,2′:5,6]thiopyrano[4,3- d]pyrimidine-Based Antiproliferative Multikinase Inhibitors 209
Structure-Based Optimization of Tyrosine Kinase Inhibitor CLM3. Design, Synthesis, Functional Evaluation, and Molecular Modeling Studies. 208
Long Residence Time at the Neurosteroidogenic 18 kDa Translocator Protein Characterizes the Anxiolytic Ligand XBD173 207
Arylthioamides as H2S Donors:l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo 206
Geometrically Constrained Analogues N-Benzylindolylglyoxylylamides: [1,2,4]Triazino[4,3-a]benzimidazol-4(10H)-one Derivatives as Potential New Ligands at the Benzodiazepine Receptor. 205
Allosteric Modulators for Adenosine Receptors: An Alternative to the Orthosteric Ligands 204
Medicinal chemistry of indolylglyoxylamide TSPO high affinity ligands with anxiolytic-like effects 203
Studies in search for selective ligands for GABAA/BzR receptor subtypes: synthesis and biological evaluation of 4'-modified N-(benzyl)indol-3-ylglyoxylamides 202
New insights in the structure-activity relationships of 2-phenylamino-substituted benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors 202
Pyrido[1,2-a]pyrimidin-4-one derivatives as a novel class of selective aldose reductase inhibitors exhibiting antioxidant activity 201
3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: a novel template for the design of highly selective A(2B) adenosine receptor antagonists 201
Drug-target Residence Time: a key parameter in glial responses to TSPO ligands 201
Residence Time (RT), a new parameter to predict neurosteroidogenic efficacy of Translocator Protein (TSPO) ligands: N,N-dialkyl-2-arylindol-3-ylglyoxylamides, a case study 199
2-(Benzimidazol-2-yl)quinoxalines: A Novel Class of selective Antagonists at Human A1 and A3 Adenosine Receptors Designed by 3D Database Searching 198
11C-ER176, a radioligand for 18-kDa translocator protein, has adequate sensitivity to robustly image all three affinity genotypes in human brain 198
Novel fluorescent triazinobenzimidazole derivatives as probes for labelling human A1 and A2B adenosine receptor subtypes 198
Benzothiopyranoindole-Based Antiproliferative Agents: Synthesis, Cytotoxicity, Nucleic Acids Interaction, and Topoisomerases Inhibition Properties. 197
Translocator protein (tspo) ligand residence time: a new parameter to predict neurosteroidogenic efficacy for n,n-dialkyl-2-arylindol-3-ylglyoxylamides (PIGAs) 197
5-Amino-2-phenyl[1,2,3]triazolo[1,2-a][1,2,4]benzotriazin-1-one: a Versatile Scaffold to Obtain Potent and Selective A3 Adenosine Receptor Antagonists 196
Synthesis of a Novel Purine-Containing Heterocyclic Ring System: 8,10-Dimethylindolo[2',3':5,6][1,2,4]triazino[4,3-f]purine-9,11(8H,10H,13H)dione 196
“Synthesis and antiproliferative evaluation of new substituted Benzothiopyrano[4,3-c] condensed ring systems” 195
Medicinal chemistry of indolylglyoxylamide GABAA/BzR high affinity ligands: identification of novel anxiolytic/non sedative agents 195
"2-Phenyl[1,2,3]triazole[1,2-a][1,2,4]triazin-1,5(6H)-dione: a derivative of a new tricyclic heteroaromatic system with high affinity at the benzodiazepine receptor" 194
Refinement of Structure-activity Relationships of the Triazinobenzimidazole A1AR Antagonists 194
Osteoblast differentiation and survival: A role for A2B adenosine receptor allosteric modulators. 194
The Anxiolytic Etifoxine Binds to TSPO Ro5-4864 Binding Site with Long Residence Time Showing a High Neurosteroidogenic Activity 194
Benzo[d]isothiazoles and Matrix Metalloproteinases. Searching for Novel and Selective Inhibitors of MMP9 193
Novel positive allosteric modulators of A2B adenosine receptor acting as bone mineralisation promoters 193
Structural requirements to obtain highly potent and selective 18 kDa Translocator Protein (TSPO) ligands 192
Recent Advances in the Development of Dual Topoisomerase I and II Inhibitors as Anticancer Drugs 192
The human microglial surveillant phenotype is preserved by de novo neurosteroidogenesis through the control of cholesterol homeostasis: Crucial role of 18 kDa Translocator Protein 191
Targeting TSPO Reduces Inflammation and Apoptosis in an In Vitro Photoreceptor-Like Model of Retinal Degeneration 190
3-(Fur-2-yl)-10-(2-Phenylethyl)-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one, a Novel Adenosine Receptor Antagonist with (2A)-Mediated Neuroprotective EffeCTS 190
Inhibition studies on carbonic anhydrase isoforms I, II, IV and IX with N-arylsubstituted secondary sulfonamides featuring a bicyclic tetrahydroindazole scaffold 190
New antiproliferative agents derived from tricyclic 3,4-dihydrobenzo[4,5]imidazo[1,2-a][1,3,5]triazine scaffold: synthesis and pharmacological effects 189
Discovery of the First-in-Class Dual TSPO/Carbonic Anhydrase Modulators with Promising Neurotrophic Activity 189
An irreversible ligand of the 18 kDa Translocator Protein induces rapidly ΔΨm collapse and activates apoptosis in human glioblastoma multiforme cells. 188
Sex Differences in Blood Accumulation of Neurodegenerative-Related Proteins and Antioxidant Responses to Regular Physical Exercise 187
Novel Pyrazolo[3,4-d]pyrimidine Derivatives as ATP-competitive Inhibitors of the Epidermal Growth Factor Receptor Protein Tyrosine Kinase 187
Targeting the 18-kDa translocator protein: Recent perspectives for neuroprotection 186
Modulation of A2B adenosine receptor by 1-benzyl-3-ketoindole derivatives 186
Novel N(2)-Substituted Pyrazolo[3,4-d]pyrimidine Adenosine A(3) Receptor Antagonists: Inhibition of A(3)-Mediated Human Glioblastoma Cell Proliferation (dagger) 184
Novel Potent and Selective Human Adenosine A3 Receptor Antagonists Containing the Pyrazolo[3,4-d]pyrimidine Ring System. Synthesis and Biological Evaluation 183
Characterization of a new fluorescent irreversible ligand to translocator protein (18 kDa) 181
4-Substituted Benzenesulfonamides Incorporating Bi/Tricyclic Moieties Act as Potent and Isoform-Selective Carbonic Anhydrase II/IX Inhibitors 181
Modulation of A2B Adenosine Receptor by 1-Benzyl-3-ketoindole Derivatives 180
Antitumoral effect by induction of collapse of mitochondrial membrane potential in Glioblastoma Multiforme cells 179
Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: Synthesis and biological evaluation. 179
Acetic acid aldose reductase inhibitors bearing a five-membered heterocyclic core with potent topical activity in a visual impairment rat model 178
Long lasting MDM2/Translocator protein modulator: a new strategy for irreversible apoptosis of human glioblastoma cells 178
De novo neurosteroidogenesis in human microglia: Involvement of the 18 kda translocator protein 178
Pyrazolo[3,4,-d]pyrimidine-4-one Derivatives as Novel and Potent Inhibitors of Adenosine Deaminase 176
Carbonic anhydrase activation profile of indole-based derivatives 176
Highlighting the new advances in drug discovery and development 175
Synthesis and Biological Evaluation of 4-Phenylquinazoline-2-carboxamides Designed as a Novel Class of Potent Ligands of the Translocator Protein 174
Anxiolytic properties of a 2-phenylindolglyoxylamide TSPO ligand: Stimulation of in vitro neurosteroid production affecting GABA(A) receptor activity 174
null 173
Nuovi derivati acidi acetici quali potenti inibitori dell’Aldoso Reduttasi 173
H2S-RELEASING PROPERTIES OF NEW THIOAMIDE, IMINOTHIOETHER AND ISOTHIOCYANATE DERIVATIVES 173
Geometrically Constrained Derivatives of Indolylglyoxylamides as Ligands Binding the GABAA/BzR Complex. 173
Iminothioethers as a novel class of H2S-donor: gasotransmitter release and vascular effects 173
Synthesis of Pyrimido[1,2-a]benzimidazol-4(10H)-one Derivatives and Evaluation of their Interactions with DNA 172
New fluorescent probes for the pheripheral-type benzodiazepine receptor: synthesis and biological application 172
Totale 21.245
Salva come PNG Salva come JPEG
Categoria #
all - tutte 114.367
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 114.367
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.583 0 229 119 142 421 377 100 116 95 72 147 765
2022/20233.787 449 581 274 373 421 483 39 276 643 22 177 49
2023/20242.829 310 282 306 190 406 505 174 72 39 68 165 312
2024/20258.212 60 286 103 526 853 829 570 370 754 1.061 872 1.928
2025/202610.170 472 1.134 1.085 774 978 791 2.200 478 655 916 400 287
2026/20271.511 340 1.171 0 0 0 0 0 0 0 0 0 0
Totale 41.868